Thyrocare shares jump 6% after firm's Q3 net profit rises 24% to Rs 19 crore

Thyrocare shares jump 6% after firm's Q3 net profit rises 24% to Rs 19 crore

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Shares of Thyrocare Technologies jumped over 6 percent in early trade on January 24 to hit an intraday high of Rs 867.95 apiece. This comes after the diagnostics company reported a 24 percent year-on-year rise in net profit to Rs 19.11 crore in the October-December quarter of FY25.

The stock later pared some gains and was trading at around Rs 834 (over 2 percent higher) at 9.36 am. The firm had announced its Q3 results in the post market hours of January 23.

Although the company's consolidated net profit saw a strong rise from Q3 of the previous financial year, it fell sequentially over 28 percent from Rs 26.67 crore net profit reported in Q2 of FY 25.

Thyrocare Technologies reported revenue from operations at Rs 165.92 crore in the reported quarter. This marks an increase of over 23 percent from the Rs 134.74 crore revenue generated in the corresponding quarter of FY24. It too, however, fell sequentially over 6 percent from Rs 177.36 crore reported in Q2.

Follow our LIVE blog on Q3 results

The company's total income in Q3 rose nearly 24 percent on-year to Rs 169.93 crore. It had reported a total income of Rs 137.47 in Q3 of the previous financial year. However, the total income also fell sequentially from Q2.

Thyrocare Technologies saw a 32 percent on-year rise in consolidated reported EBITDA, which jumped to Rs 41.6 crore in Q3 FY25. Its reported EBITDA margin stood at 25 percent.

Along with the Q3 results, Thyrocare Technologies also announced the retirement of Ramjee Dorai as the Company Secretary and Compliance Officer, effective from January 31. Brijesh Kumar was appointed to replace Dorai.

The company said it has allotted 1,651 equity shares as part of the Employee Stock Option Scheme (ESOS).

Notably, Thyrocare stock was bucking the trend, while its peers were trading in the red. Shares of Krsnaa Diagnostics had fallen nearly 2 percent to trade at Rs 821, while those of Dr. Lal PathLabs were down 1.29 percent at Rs 2,839. Vijaya Diagnostic Centre shares saw the worst fall, trading nearly 3 percent lower at Rs 993.90.